BioFire

The contract involves the purchase or lease of an FDA-approved PCR analyzer, such as the Spotfire 2 or an equivalent CLIA-waived device, capable of testing multiple respiratory pathogens from a single sample. These pathogens include adenoviruses, multiple strains of coronavirus (including SARS-CoV-2 and seasonal variants), human metapneumovirus, rhinovirus/enterovirus, various influenza subtypes, respiratory syncytial virus, and bacteria such as Bordetella parapertussis, Bordetella pertussis, Chlamydia pneumonia, and Mycoplasma pneumonia. The procurement also includes test panels compatible with this analyzer to support diagnostic testing. This contract is forecasted by the Indian Health Service under NAICS code 423450, which pertains to medical and diagnostic equipment distribution. Key contacts include Benjamin Olson as the program point of contact and Maryann Yocham as the contracting officer. While location specifics are not detailed, the acquisition aims to enhance the agency’s capability in point-of-care respiratory diagnostics, leveraging advanced multiplex PCR technology for comprehensive pathogen detection from a single patient sample.